Key result
This review summarizes the principal results of the HOT and CAPPP trials and provides an update on ongoing hypertension intervention trials initiated in Sweden, with no quantitative data reported.
This review summarizes key findings from major Swedish-initiated hypertension trials (HOT, CAPPP) and provides updates on ongoing studies.
In 1998 the final results were presented of two large intervention trials in hypertension, the Hypertension Optimal Treatment Study (HOT) and the Captopril Prevention Project (CAPPP). Both were initiated from Sweden although the HOT Study was conducted in 26 countries worldwide and the CAPPP Study in Finland and Sweden. The HOT and CAPPP trials and their principal results will be reviewed briefly here. In addition a brief up-date will be provided of three ongoing intervention trials in hypertension that were also initiated from Sweden: the Swedish Trial in Old Patients with Hypertension-2 (STOP-Hypertension-), the Nordic Diltiazem (NORDIL) Study and the Study on Cognition and Prognosis in Elderly Hypertensives (SCOPE).
No takes yet. Share an insight, caveat, or question.
Lennart Hansson (1999) conducted a review in Hypertension. Hypertension intervention trials (HOT, CAPPP, STOP-Hypertension-2, NORDIL, SCOPE) was evaluated. This review summarizes the principal results of the HOT and CAPPP trials and provides an update on ongoing hypertension intervention trials initiated in Sweden, with no quantitative data reported.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: